These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of ibopamine in congestive heart failure. van Veldhuisen DJ; Girbes AR; Crijns HJ; Smit AJ; de Graeff PA; Lie KI J Auton Pharmacol; 1990; 10 Suppl 1():s115-21. PubMed ID: 1983005 [TBL] [Abstract][Full Text] [Related]
3. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585 [TBL] [Abstract][Full Text] [Related]
4. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine. Metra M; Missale C; Spano PF; Cas LD J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152 [TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure. Dei Cas L; Metra M; Visioli O Am J Cardiol; 1992 Sep; 70(6):629-34. PubMed ID: 1354938 [TBL] [Abstract][Full Text] [Related]
6. The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines. Van Veldhuisen DJ; Girbes AR; Crijns HJ; Smit AJ; Van Gilst WH; Lie KI Int J Clin Pharmacol Res; 1991; 11(3):159-65. PubMed ID: 1687321 [TBL] [Abstract][Full Text] [Related]
7. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure. Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627 [TBL] [Abstract][Full Text] [Related]
8. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256 [TBL] [Abstract][Full Text] [Related]
9. Haemodynamic evaluation of ibopamine in severe congestive heart failure. Reffo GC; Turrin M; Gabellini A; Forattini C Eur J Clin Pharmacol; 1984; 26(1):19-22. PubMed ID: 6714289 [TBL] [Abstract][Full Text] [Related]
10. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure. Ghirardi P; Brusoni B; Mangiavacchi M; Bianco L; Col J; Metra M; Dei Cas L Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102 [TBL] [Abstract][Full Text] [Related]
11. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias. Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias. Cocchieri M; Alunni GF; Del Favero A; Fortunati F; Bardelli G; Capponi EA; Regi L; Boschetti E Cardiology; 1990; 77 Suppl 5():36-42. PubMed ID: 2126222 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations. Dei Cas L; Metra M; Nodari S; Visioli O J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436 [TBL] [Abstract][Full Text] [Related]
15. Effect of ibopamine, a dopamine congener, on arrhythmias in heart failure. Storstein L Cardiology; 1990; 77 Suppl 5():30-5. PubMed ID: 1980632 [TBL] [Abstract][Full Text] [Related]
16. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure. Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968 [TBL] [Abstract][Full Text] [Related]
17. The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure. Leier CV; Ren JH; Huss P; Unverferth DV Pharmacotherapy; 1986; 6(1):35-40. PubMed ID: 3952005 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure. Sannia L; Ibba GV; Castellaccio M; Dore L Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure. Gavazzi A; Mussini A; Bramucci E Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652 [TBL] [Abstract][Full Text] [Related]
20. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure. Naccarelli GV; Gray EL; Dougherty AH; Hanna JE; Goldstein RA Am J Cardiol; 1984 Sep; 54(6):600-4. PubMed ID: 6475780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]